MX2018013133A - Compuesto de pirazolo[1,5-a]pirimidina. - Google Patents
Compuesto de pirazolo[1,5-a]pirimidina.Info
- Publication number
- MX2018013133A MX2018013133A MX2018013133A MX2018013133A MX2018013133A MX 2018013133 A MX2018013133 A MX 2018013133A MX 2018013133 A MX2018013133 A MX 2018013133A MX 2018013133 A MX2018013133 A MX 2018013133A MX 2018013133 A MX2018013133 A MX 2018013133A
- Authority
- MX
- Mexico
- Prior art keywords
- pirazolo
- pyrimidine
- compound
- formulas
- xviii
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Los compuestos representados por las fórmulas (I) a (XVIII) o sales farmacéuticamente aceptables de los mismos. (ver Fórmulas).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016169507 | 2016-08-31 | ||
| PCT/JP2017/030865 WO2018043461A1 (ja) | 2016-08-31 | 2017-08-29 | ピラゾロ［１，５－ａ］ピリミジン化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018013133A true MX2018013133A (es) | 2019-02-21 |
| MX377489B MX377489B (es) | 2025-03-10 |
Family
ID=61241576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018013133A MX377489B (es) | 2016-08-31 | 2017-08-29 | Compuesto de pirazolo[1,5-a]pirimidina. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10227349B2 (es) |
| EP (1) | EP3508487B1 (es) |
| JP (1) | JP6916799B2 (es) |
| KR (1) | KR102388621B1 (es) |
| CN (1) | CN109071554B (es) |
| AU (1) | AU2017319080B2 (es) |
| CA (1) | CA3021675C (es) |
| ES (1) | ES2886840T3 (es) |
| IL (1) | IL262673A (es) |
| MX (1) | MX377489B (es) |
| RU (1) | RU2739983C2 (es) |
| TW (1) | TWI732031B (es) |
| WO (1) | WO2018043461A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102723164B1 (ko) | 2018-02-26 | 2024-10-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 피라졸로[1,5-a]피리미딘 화합물의 염 및 이의 결정 |
| JP7150308B2 (ja) * | 2018-07-06 | 2022-10-11 | 国立大学法人京都大学 | 皮膚外用組成物 |
| WO2021106864A1 (en) | 2019-11-25 | 2021-06-03 | Eisai R&D Management Co., Ltd. | Process for the preparation of producing pyrazolo[1,5-a] pyrimidine derivatives |
| US20240066027A1 (en) | 2020-12-03 | 2024-02-29 | Domain Therapeutics | Novel par-2 inhibitors |
| AU2022285372A1 (en) | 2021-06-02 | 2023-11-30 | Otsuka Pharmaceutical Co., Ltd. | Pyrazolo[1,5-a]pyrimidine compound for the treatment of dermal disorders |
| AU2023279857A1 (en) | 2022-06-03 | 2024-11-14 | Domain Therapeutics | Novel par-2 inhibitors |
| WO2025172573A1 (en) | 2024-02-16 | 2025-08-21 | Domain Therapeutics | Combinations of par2 inhibitors and immune checkpoint inhibitors for the treatment of cancer |
| WO2025191185A1 (en) | 2024-03-15 | 2025-09-18 | Domain Therapeutics | Azine-based compounds as par-2 inhibitors and therapeutic uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6833371B2 (en) * | 2001-11-01 | 2004-12-21 | Icagen, Inc. | Pyrazolopyrimidines |
| JP2003286171A (ja) | 2002-03-28 | 2003-10-07 | Sumitomo Pharmaceut Co Ltd | Ｐａｒ阻害剤 |
| JP2004170323A (ja) | 2002-11-22 | 2004-06-17 | Sumitomo Pharmaceut Co Ltd | 皮膚疾患治療剤のスクリーニング方法 |
| MXPA05013151A (es) | 2003-06-04 | 2006-03-17 | Merck & Co Inc | 3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b. |
| WO2005030773A1 (ja) * | 2003-09-26 | 2005-04-07 | Dainippon Sumitomo Pharma Co., Ltd. | 新規ピラゾロピリミジン誘導体 |
| NZ596213A (en) | 2009-04-08 | 2013-05-31 | Actelion Pharmaceuticals Ltd | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adenosine 5'-diphosphate (ADP) receptor antagonists |
| BR112012021198B1 (pt) * | 2010-02-26 | 2021-12-14 | Mitsubishi Tanabe Pharma Corporation | Compostos de pirazolopirimidina, composições relacionadas e seu uso como inibidores de pde10 |
| ES2617339T3 (es) | 2010-12-16 | 2017-06-16 | Calchan Limited | Derivados de pirrolopirimidina inhibidores de ASK1 |
| GB201101517D0 (en) | 2011-01-28 | 2011-03-16 | Proximagen Ltd | Receptor antagonists |
| JP5531066B2 (ja) * | 2011-08-24 | 2014-06-25 | 田辺三菱製薬株式会社 | ピラゾロピリミジン化合物及びｐｄｅ１０阻害剤としてのその使用 |
| EP3049418A1 (en) | 2013-09-25 | 2016-08-03 | Vertex Pharmaceuticals Incorporated | Imidazopyridazines useful as inhibitors of the par-2 signaling pathway |
-
2017
- 2017-08-29 KR KR1020187035388A patent/KR102388621B1/ko active Active
- 2017-08-29 EP EP17846466.5A patent/EP3508487B1/en active Active
- 2017-08-29 JP JP2018537286A patent/JP6916799B2/ja active Active
- 2017-08-29 TW TW106129244A patent/TWI732031B/zh active
- 2017-08-29 US US15/689,481 patent/US10227349B2/en active Active
- 2017-08-29 RU RU2019102674A patent/RU2739983C2/ru active
- 2017-08-29 WO PCT/JP2017/030865 patent/WO2018043461A1/ja not_active Ceased
- 2017-08-29 MX MX2018013133A patent/MX377489B/es active IP Right Grant
- 2017-08-29 CN CN201780025829.9A patent/CN109071554B/zh active Active
- 2017-08-29 AU AU2017319080A patent/AU2017319080B2/en active Active
- 2017-08-29 CA CA3021675A patent/CA3021675C/en active Active
- 2017-08-29 ES ES17846466T patent/ES2886840T3/es active Active
-
2018
- 2018-10-29 IL IL262673A patent/IL262673A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2739983C2 (ru) | 2020-12-30 |
| KR20190039884A (ko) | 2019-04-16 |
| EP3508487A1 (en) | 2019-07-10 |
| CA3021675A1 (en) | 2018-03-08 |
| EP3508487A4 (en) | 2020-03-18 |
| CA3021675C (en) | 2024-06-25 |
| US20180057499A1 (en) | 2018-03-01 |
| BR112019001968A2 (pt) | 2019-05-07 |
| CN109071554A (zh) | 2018-12-21 |
| EP3508487B1 (en) | 2021-06-16 |
| ES2886840T3 (es) | 2021-12-21 |
| RU2019102674A3 (es) | 2020-10-02 |
| AU2017319080B2 (en) | 2020-12-17 |
| TWI732031B (zh) | 2021-07-01 |
| AU2017319080A1 (en) | 2018-11-22 |
| TW201811796A (zh) | 2018-04-01 |
| US10227349B2 (en) | 2019-03-12 |
| MX377489B (es) | 2025-03-10 |
| JPWO2018043461A1 (ja) | 2019-06-24 |
| CN109071554B (zh) | 2021-03-16 |
| KR102388621B1 (ko) | 2022-04-21 |
| RU2019102674A (ru) | 2020-10-02 |
| WO2018043461A1 (ja) | 2018-03-08 |
| JP6916799B2 (ja) | 2021-08-11 |
| IL262673A (en) | 2018-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018013133A (es) | Compuesto de pirazolo[1,5-a]pirimidina. | |
| CY1124800T1 (el) | Παραγωγο πυριδο[3,4-d]πυριμιδινης και φαρμακευτικως αποδεκτο αλας αυτου | |
| DK3577110T3 (da) | 8-oxetan-3-yl-3,8-diazabicyclo[3.2.1]octan-3-yl-substituerede forbindelser som hiv-inhibitorer | |
| CR20160291A (es) | Análogos de cortistatina y síntesis y usos de los mismos | |
| UY35834A (es) | Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon | |
| PE20150332A1 (es) | Imidazotriazincarbonitrilos utiles como inhibidores de cinasa | |
| CR20150472A (es) | USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRANSTORNOS RELACIONADOS CON LA PI3Kd | |
| CR20160523A (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer | |
| BR112017019286A2 (pt) | composto de fórmula (i) ou um sal farmaceuticamente aceitável deste | |
| MX373716B (es) | Compuesto de pirazol-amida y sus usos farmaceuticos. | |
| CL2020000376A1 (es) | Compuesto pentacíclico. | |
| ECSP18074962A (es) | Derivados de aminotiazol útiles como agentes antivíricos | |
| MX387483B (es) | Preparación farmacéutica. | |
| AU2015211852A1 (en) | Heterocyclic sulfonamide derivative and medicine comprising same | |
| CL2019001694A1 (es) | Compuestos de pirazolopirimidina y métodos de uso de los mismos. | |
| CL2018001067A1 (es) | Compuesto piranodipiridínico. | |
| MX2019005803A (es) | Derivado de pirido[3,4-d]pirimidina y su sal farmaceuticamente aceptable. | |
| EA201892449A1 (ru) | Конденсированные гетероциклические соединения | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| DK3083627T3 (da) | [1,2,4]triazol[1,5-a]pyrimidinderivater som protozoiske proteasominhibitorer til behandling af parasitsygdomme, såsom leishmaniasis | |
| PH12019500370A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
| BR112016022437A2 (pt) | Processo para preparação de (2s,5r)-6-(benziloxi)-7-oxo-1,6- diazabiciclo[3,2,1]octano-2-carboxilato de sódio | |
| AR092772A1 (es) | Derivado de 7-azaindol | |
| CY1122375T1 (el) | Συμπυκνωμενα με τετραϋδροφουρανιο αμινοϋδροθειαζινικα αναλογα τα οποια ειναι χρησιμα στη θεραπεια της νοσου toy alzheimer | |
| EA201690908A1 (ru) | Пиразолопиримидиновые соединения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |